Biovail Walks The Walk: More CNS Licensing, Acquisitions Planned For 2010
Executive Summary
Biovail is putting its money where its mouth is. The Toronto-based specialty pharma announced plans early in 2008 to turn itself into a specialty central nervous system company, and - after five deals in 18 months -Biovail execs are more excited than ever about the opportunities open to them